About ReShape
ReShape is a company based in San Clemente (United States) founded in 2005 was acquired by EnteroMedics in October 2017.. ReShape has raised $90.32 million across 9 funding rounds from investors including SVB, New Leaf Venture Partners and Oxford Finance. ReShape offers products and services including LAP-BAND, ReShape Vest, and ReShape Care. ReShape operates in a competitive market with competitors including Apollo Endo, USGI Medical, Vibrynt, Satiety and Barosense, among others.
- Headquarter San Clemente, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Reshape Lifesciences Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$90.32 M (USD)
in 9 rounds
-
Latest Funding Round
$11 M (USD), Debt – Conventional
Feb 13, 2017
-
Investors
SVB
& 8 more
-
Employee Count
Employee Count
-
Acquired by
EnteroMedics
(Oct 03, 2017)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of ReShape
ReShape offers a comprehensive portfolio of products and services, including LAP-BAND, ReShape Vest, and ReShape Care. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Minimally invasive device for long-term obesity treatment.
Laparoscopically implanted system for rapid weight loss.
Virtual tele-health coaching for sustained weight management.
Funding Insights of ReShape
ReShape has successfully raised a total of $90.32M across 9 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $11 million completed in February 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 9
- Last Round Debt – Conventional — $11.0M
-
First Round
First Round
(31 Aug 2007)
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2017 | Amount | Debt – Conventional - ReShape | Valuation |
investors |
|
| Aug, 2015 | Amount | Series D - ReShape | Valuation | HealthCor Partners | |
| Apr, 2015 | Amount | Debt – Conventional - ReShape | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in ReShape
ReShape has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include SVB, New Leaf Venture Partners and Oxford Finance. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Endeavour Vision is focused on transformative healthcare technology investments.
|
Founded Year | Domain | Location | |
|
Stage-agnostic investments in US life sciences are managed.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by ReShape
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - ReShape
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Reshape Comparisons
Competitors of ReShape
ReShape operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Apollo Endo, USGI Medical, Vibrynt, Satiety and Barosense, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutic devices for obesity and GI disorders are developed.
|
|
| domain | founded_year | HQ Location |
Incisionless operating platform for weight loss surgery
|
|
| domain | founded_year | HQ Location |
Provides durable coat hooks and storage solutions for home use.
|
|
| domain | founded_year | HQ Location |
Develops a device for transoral gastroplasty to induce satiety through endoscopic methods.
|
|
| domain | founded_year | HQ Location |
Restrictive gastric implants and procedures are developed to induce satiety.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about ReShape
When was ReShape founded?
ReShape was founded in 2005 and raised its 1st funding round 2 years after it was founded.
Where is ReShape located?
ReShape is headquartered in San Clemente, United States. It is registered at San Clemente, California, United States.
Who is the current CEO of ReShape?
Michael Mangano is the current CEO of ReShape.
Is ReShape a funded company?
ReShape is a funded company, having raised a total of $90.32M across 9 funding rounds to date. The company's 1st funding round was a Debt – Conventional of $12M, raised on Aug 31, 2007.
What does ReShape do?
ReShape Medical has developed the ReShape Dual Balloon, a dual intra-gastric balloon system for weight loss. It is inserted into the stomach through an endoscopic procedure and filled with saline (salt water). The balloons remain in the stomach for six months and help reduce hunger. Insertion of the gastric balloon is completed in about 20 minutes, with no hospital stay required. The company has received FDA approval for its ReShape Integrated Dual Balloon system.
Who are the top competitors of ReShape?
ReShape's top competitors include Apollo Endo, USGI Medical and Barosense.
What products or services does ReShape offer?
ReShape offers LAP-BAND, ReShape Vest, and ReShape Care.
Who are ReShape's investors?
ReShape has 9 investors. Key investors include SVB, New Leaf Venture Partners, Oxford Finance, EnteroMedics, and HealthCor Partners.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.